Understanding the Impact of Sepsis and Septic Shock
Sepsis and septic shock pose serious threats in critical healthcare settings. Each year, millions of people are affected by these life-threatening conditions. Recognizing the need for innovative solutions, CytoSorbents Corporation has been at the forefront, utilizing its proprietary blood purification technologies to address critical care challenges.
Upcoming Global Webinar Details
CytoSorbents is hosting a global webinar, "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb," in alignment with World Sepsis Day. This event promises to be an enlightening session where healthcare professionals can glean crucial insights from leading international experts dedicated to tackling these severe illnesses.
Date and Time
The training webinar is scheduled for Wednesday, September 10, at 11 AM EDT. Registration is essential, and participants can expect an engaging session with various panel discussions.
Focus and Speaker Lineup
The event will be moderated by Dr. Phillip Chan, CEO of CytoSorbents. He will lead discussions with a panel consisting of esteemed professionals from the field of critical care medicine who will share their insights on improving clinical outcomes with CytoSorb, a device integral to the treatment of sepsis and septic shock.
Highlighted Themes of the Webinar
During the webinar, panelists will explore several critical topics:
- The current understanding of CytoSorb's role in complementing antibiotic treatments for sepsis.
- Best practices for implementation of CytoSorb in clinical settings.
- Real-world evidence supporting the timeline and efficacy of using CytoSorb in patient treatment.
- Strategies for preventing organ failure through effective sepsis management.
Testimonials from Leading Experts
Experts participating in this informative webinar have extensive experience utilizing the CytoSorb therapy. Their shared knowledge promises to empower healthcare providers to enhance patient recovery and outcomes in crises of sepsis and septic shock.
Panelist Highlights
The panel will feature clinicians like Dr. med. Tobias Hübner, a Chief Physician in the Intensive Care Unit, and Prof. Dr. Zsolt Molnár, leading a department in anesthesiology and intensive therapy.
Why This Matter in Critical Care
Sepsis affects nearly 49 million people each year, leading to approximately 11 million deaths globally. The urgency for effective treatment options cannot be overstated; hence innovations like CytoSorb's blood purification therapies are crucial in advancing care protocols.
Engagement and Further Learning
Participants are encouraged to engage actively during the webinar and take advantage of the subsequent opportunities to explore the varied uses of CytoSorb in practice.
About CytoSorbents Corporation
CytoSorbents Corporation, with the ticker symbol CTSO, specializes in blood purification devices aimed at combating life-threatening conditions in intensive care environments. Their groundbreaking technology not only facilitates the removal of inflammatory agents but also assists in managing medications during surgical procedures. With a commitment to innovation, CytoSorbents continues to seek advancements in medical technology that significantly improve patient outcomes.
Frequently Asked Questions
What is the purpose of the CytoSorbents webinar?
The webinar aims to share critical insights on managing sepsis and septic shock using CytoSorb technology and expert recommendations.
When is the webinar scheduled?
The webinar is set for September 10, at 11 AM EDT.
Who are the keynote speakers for the event?
The webinar will feature a panel of leading experts in critical care medicine, including Dr. Phillip Chan.
How can I participate in the webinar?
Interested participants must register in advance to secure a spot for the informative session.
What are the main topics to be discussed?
The discussion will address sepsis treatment strategies, practical use cases for CytoSorb, and expert experiences in critical care.
